Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
COLLEGIUM PHARMACEUTICAL, INC | Director | Common Stock | 52.5K | $1.69M | $32.30 | May 16, 2024 | Direct |
Protalix BioTherapeutics, Inc. | Director | Stock Options (Right to Buy) | 61.7K | Sep 29, 2023 | Direct | ||
Gain Therapeutics, Inc. | Director | Stock Option (right to buy) | 15K | Jun 24, 2024 | Direct | ||
SOLENO THERAPEUTICS INC | Director | Stock option (right to buy) | 10K | May 26, 2023 | Direct |